A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation

BACKGROUND: We conducted a placebo-controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. METHODS: We compared azithromycin (250 mg alternate days, 12 weeks) with placebo. Primary outcome was FEV(1) change at 12 weeks. RESULTS: 48 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Corris, Paul A, Ryan, Victoria A, Small, Therese, Lordan, James, Fisher, Andrew J, Meachery, Gerard, Johnson, Gail, Ward, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413845/
https://www.ncbi.nlm.nih.gov/pubmed/25714615
http://dx.doi.org/10.1136/thoraxjnl-2014-205998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413845/
https://www.ncbi.nlm.nih.gov/pubmed/25714615
http://dx.doi.org/10.1136/thoraxjnl-2014-205998

Ejemplares similares